Decreased maternal serum cortistatin levels in pregnancies with gestational diabetes mellitus

Akbas M., Koltan S. O., Koyuncu F. M., ARTUNÇ ÜLKÜMEN B., TANELİ F., Ozdemir H.

Journal of Maternal-Fetal and Neonatal Medicine, cilt.33, sa.7, ss.1239-1244, 2020 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 7
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1080/14767058.2019.1627321
  • Dergi Adı: Journal of Maternal-Fetal and Neonatal Medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1239-1244
  • Anahtar Kelimeler: Cortistatin, gestational diabetes mellitus, insulin resistance, pregnancy
  • Manisa Celal Bayar Üniversitesi Adresli: Evet

Özet

Objective: To investigate serum cortistatin levels in women with gestational diabetes mellitus (GDM) and women with uncomplicated pregnancies. Material and methods: This case-control study consisted of 40 pregnancies with GDM and 41 healthy singleton pregnancies matched for maternal and gestational age. The maternal serum levels of cortistatin were measured with enzyme-linked immunosorbent assay and compared between groups. Results: Cortistatin levels were significantly lower in GDM group (48.85 ± 20.18 versus 65.84 ± 33.98 ng/ml, p =.008). There was a statistically significant difference in cortistatin levels between different treatment modalities and control group (χ2(2) = 8.828, p =.012). Pairwise comparisons showed that diet group had significantly lower CST levels than control group (p =.012). Serum cortistatin levels were negatively correlated with serum insulin and glucose levels and HOMA-IR (r = −0.358, p =.001; r = −0.303, p =.006; r = −0.444, p <.001, respectively). Conclusion: Cortistatin levels were significantly lower in GDM pregnancies and related to serum insulin and glucose levels and HOMA-IR in pregnancy. This may help to better clarify the mechanism of GDM pathogenesis.